≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Thyrotoxicosis with toxic multinodular goitre

DOID EFO Endpoint Browser PheWeb

E4_THYTOXGOITMULT

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E05.2
  • Hospital discharge: ICD-9 — 2422
  • Hospital discharge: ICD-8 — 2421
  • Cause of death: ICD-10 — E05.2
  • Cause of death: ICD-9 — 2422
  • Cause of death: ICD-8 — 2421

2 out of 7 registries used, show all original rules.

2195

4. Check minimum number of events

None

2195

5. Include endpoints

None

2195

6. Filter based on genotype QC (FinnGen only)

2195

Control definitions (FinnGen only)

Control exclude
THYROTOXICOSIS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E05
Name in latin
Thyreotoxicosis cum struma multinodulari

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 18329 15393 2783
Only index persons 14535 12435 2100
Unadjusted period prevalence (%)
Whole population 0.38 0.44 0.08
Only index persons 0.40 0.46 0.08
Median age at first event (years)
Whole population 60.94 60.51 63.51
Only index persons 60.38 59.55 65.30

-FinnGen-

Key figures

All Female Male
Number of individuals 2195 1782 413
Unadjusted period prevalence (%) 0.53 0.61 0.18
Median age at first event (years) 60.77 59.30 67.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1944
Matched controls
19439
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
14100.9
323.0
1600
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
743.3
323.0
580
11
H03BB01
ATC
carbimazole; oral
815.3
323.0
1174
36
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
+∞
323.0
472
*
BAA60
NOMESCO Finland
Total thyroidectomy
37.7
323.0
453
155
24210
ICD-8 Finland
Thyrotoxicosis with or without goitre, Toxic nodular goitre
+∞
316.5
295
*
H03AA01
ATC
levothyroxine sodium; systemic
6.0
286.1
1124
3592
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
37.0
247.2
320
103
104
Kela drug reimbursment
Thyroid insufficiency
8.0
221.6
566
949
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
736.1
205.4
199
*
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
9.7
159.6
346
423
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
162.4
143.6
150
10
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
55.9
142.3
169
33
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
212.0
134.6
138
7
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
21.3
122.3
184
95
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
9.5
85.2
183
211
T85
ICPC
Hyperthyroidism/thyrotoxicosis
51.1
73.1
88
18
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.7
64.1
233
542
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
+∞
63.9
61
*
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
60.7
58
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
10.4
60.6
122
124
2422A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic multinodular goitre
+∞
55.5
53
*
C07AA05
ATC
propranolol; systemic
2.5
49.0
483
2309
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
45.3
43.3
53
12
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
54.6
40.6
48
9
C07AB07
ATC
bisoprolol; oral
1.9
39.8
1058
7521
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.3
32.7
347
1682
E05.89
ICD-10 Finland
Other thyrotoxicosis
322.1
31.9
32
*
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
5.0
31.3
104
218
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
10.0
31.2
63
65
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
44.5
28.7
35
8
A11CC03
ATC
alfacalcidol; systemic
5.5
28.6
87
165
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
9.5
28.5
59
64
T86
ICPC
Hypothyroidism/myxoedema
3.5
28.3
139
419
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
27.6
830
5874
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.7
27.2
122
341
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.3
23.3
72
140
H062, E050
ICD-10 Finland
NA
+∞
23.0
22
*
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
232.6
22.7
23
*
24209
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffuse NUD
+∞
21.9
21
*
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
16.2
21.9
35
22
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.8
21.5
93
253
106
Kela drug reimbursment
Hypoparathyroidism
17.6
21.3
33
19
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
4.8
20.1
67
142
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
19.4
477
3108
E03
ICD-10 Finland
Other hypothyroidism
2.4
18.8
168
739
R94.6
ICD-10 Finland
Abnormal results of thyroid function studies
14.3
18.6
31
22
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
17.4
416
2675
T81
ICPC
Goitre
11.2
17.2
32
29
E83.51
ICD-10 Finland
Hypocalcemia
13.4
17.0
29
22
24200
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi
+∞
16.7
16
*
H03BA02
ATC
propylthiouracil; oral
+∞
16.7
16
*
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
4.8
16.5
55
118
WX402
NOMESCO Finland
General anaesthesia
1.8
16.4
316
1898
B01AA03
ATC
warfarin; systemic
1.7
15.4
406
2671
E04.8
ICD-10 Finland
Other specified nontoxic goitre
12.0
14.6
26
22
N02BE01
ATC
paracetamol; systemic, rectal
1.6
14.3
1660
15167
ZXA10
NOMESCO Finland
Bilateral
1.6
14.3
404
2702
207
Kela drug reimbursment
Chronic arrhythmias
1.7
14.2
308
1912
A11CC02
ATC
dihydrotachysterol; oral
22.4
14.2
20
9
TFP20
NOMESCO Finland
Cardiodefibrillation
2.2
13.7
144
685
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
13.7
487
3450
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
13.4
299
1873
GB1AA
NOMESCO Finland
Tracheal X-ray examination
21.3
13.3
19
9
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
21.3
13.3
19
9
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.8
13.2
265
1607
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
12.9
280
1737
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
7.9
12.6
28
36
24400
ICD-8 Finland
Myxoedema, (hypothyreosis) post therapiam
32.2
12.6
16
5
C03CA01
ATC
furosemide; systemic
1.5
12.3
598
4518
R06.0
ICD-10 Finland
Dyspnoea
1.5
12.2
481
3475
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.0
12.0
167
892
C07AA07
ATC
sotalol; systemic
2.5
12.0
94
388
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
12.0
326
2151
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
6.5
11.9
30
47
L28
ICPC
Limited function/disability (L)
1.6
11.8
324
2144
E05.5
ICD-10 Finland
Thyroid crisis or storm
+∞
11.5
11
*
R4110
NOMESCO Finland
Physiotherapy
1.5
10.8
493
3656
H05.2
ICD-10 Finland
Exophthalmic conditions
15.6
10.8
17
11
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
10.8
1146
9900
24220
ICD-8 Finland
Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre
+∞
10.4
10
*
A12AA04
ATC
calcium carbonate; oral
4.1
10.3
39
97
C07AB02
ATC
metoprolol; systemic
1.5
10.1
420
3051
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
9.5
359
2552
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
+∞
9.4
9
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
9.0
789
6529
R53
ICD-10 Finland
Malaise and fatigue
1.5
9.0
381
2771
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
18.7
8.9
13
7
E04
ICD-10 Finland
Other nontoxic goitre
7.5
8.9
20
27
ZXA05
NOMESCO Finland
Left side
1.4
8.8
487
3726
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
8.8
150
863
2419X
ICD-9 Finland
Non-toxic nodular goitre, Unspecified non-toxic nodular goitre
8.6
8.8
18
21
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.3
8.7
78
346
Z01.7
ICD-10 Finland
Laboratory examination
1.6
8.5
197
1246
R03BB04
ATC
tiotropium bromide; inhalant
1.7
8.4
176
1079
J01DA01
ATC
[U] cefalexin; systemic
1.3
8.2
1117
9827
R00.2
ICD-10 Finland
Palpitations
1.8
8.1
127
711
C01AA05
ATC
digoxin; systemic
1.7
7.5
162
999
K78
ICPC
Atrial fibrillation/flutter
1.7
7.5
147
886
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
3.3
7.5
35
107
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
7.4
287
2044
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
6.5
7.4
18
28
C03DA01
ATC
spironolactone; oral
1.6
7.4
198
1299
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
7.3
369
2765
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
7.3
834
7112
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.4
7.3
57
237
B01AB05
ATC
enoxaparin; parenteral
1.3
7.2
565
4556
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.2
527
4213
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
30.1
7.1
9
*
J01DB01
ATC
cefalexin; oral
1.3
7.1
1448
13346
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
7.0
404
3103
E07.9
ICD-10 Finland
Disorder of thyroid, unspecified
7.5
6.9
15
20
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
6.9
173
1114
Z71.8
ICD-10 Finland
Other specified counselling
1.4
6.8
378
2879
A02BC02
ATC
pantoprazole; systemic
1.3
6.7
1198
10788
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
6.7
276
1991
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
6.6
270
1942
R03AC02
ATC
salbutamol; inhalant
1.3
6.6
904
7858
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
12.3
6.6
11
9
WZC30
NOMESCO Finland
Teaching
1.5
6.5
214
1472
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
6.5
369
2823
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
6.5
166
1078
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.0
6.5
81
419
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
6.5
475
3787
J01AA02
ATC
doxycycline; systemic
1.3
6.5
1428
13192
A27
ICPC
Fear of other disease NOS
1.9
6.4
87
468
2504
FHL
Unilateral resection or enucleation
3.5
6.3
27
78
E05.3
ICD-10 Finland
Thyrotoxicosis from ectopic thyroid tissue
+∞
6.3
6
*
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
+∞
6.3
6
*
WX892
NOMESCO Finland
Monitored bed care
1.7
6.2
120
718
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
6.1
236
1682
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
6.0
501
4058
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.8
6.0
36
131

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1118
947
23.02
307.65
5.4
2.4
pmol/l
4.8
4.3
25.61
1035
809
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
892
255
58.24
307.65
1.8
1.2
iu/l
24.9
2.8
0.84
299
48
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
500
1114
5.52
218.70
1.3
1.2
iu/ml
98.9
133.2
0.81
150
399
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1990
14579
4.91
119.48
12.2
4.1
pmol/l
15.7
14.9
36.93
1913
13100
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1482
9988
2.49
85.40
7.7
6.3
mmol/l
1.2
1.2
3.32
1271
8360
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
210
507
4.47
80.04
1.2
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
428
1661
2.96
79.10
3.3
3.4
ng/l
67.9
87.2
5.72
378
1376
(3018418) pH of Serum or Plasma
1010
5980
2.28
75.39
5.3
3.8
ph
7.4
7.4
0.21
188
1128
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1337
9055
2.22
69.48
6.7
5.6
mmol/l
1.2
1.2
4.04
1255
8085
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2019
17101
3.25
53.17
13.6
5.0
mu/l
1.5
2.1
5.95
1940
15439
(3013650) Neutrophils [#/volume] in Blood by Automated count
1444
10753
2.00
50.04
8.7
8.8
e9/l
4.0
4.1
0.26
1236
9333
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
51
60
8.68
40.06
1.6
1.5
pmol/l
15.7
14.8
0.61
46
48
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1145
8393
1.76
36.25
2.6
2.3
nmol/l
78.0
80.1
1.88
1041
7400
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
78
165
4.86
34.73
4.3
4.7
u/ml
120.0
59.7
0.30
16
49
(40758558) Short blood count panel - Blood
722
4770
1.77
31.76
6.5
6.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1657
13967
1.76
27.72
4.4
4.3
mm/h
13.7
13.7
0.05
1567
12788
(3044640) Blood type and Crossmatch panel - Blood
849
6075
1.65
26.66
2.3
2.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
110
363
3.14
26.19
1.9
2.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
54
109
5.05
25.41
5.6
6.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
687
4716
1.66
25.02
4.2
3.7
%
88.7
91.0
1.38
674
4586
(3021589) Normoblasts [#/volume] in Blood
1056
8082
1.59
24.49
10.4
9.6
e9/l
0.0
0.0
1.43
840
6539
(3022096) Basophils/100 leukocytes in Blood
1073
8323
1.57
22.92
5.8
5.8
%
0.6
0.7
1.32
991
7687
(42870588) Differential panel, method unspecified - Blood
849
6288
1.57
21.93
5.1
5.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1689
14638
1.67
21.82
8.2
7.4
u/l
78.5
79.0
0.25
1623
13635
(3013826) Glucose [Moles/volume] in Serum or Plasma
1340
10999
1.56
21.75
5.2
4.4
mmol/l
6.7
6.7
0.14
1280
10287
(3002582) Erythrocytes [#/volume] in Urine
775
5648
1.58
21.33
3.8
3.2
e6/l
98.8
69.8
0.21
584
4285
(3015377) Calcium [Moles/volume] in Serum or Plasma
930
7072
1.55
21.13
3.5
3.4
mmol/l
2.4
2.4
2.00
825
6069
(3006504) Eosinophils/100 leukocytes in Blood
1087
8554
1.54
21.10
5.8
5.8
%
2.8
2.8
0.04
1005
7887
(3019069) Monocytes/100 leukocytes in Blood
1090
8588
1.53
21.01
5.9
6.1
%
8.6
8.6
0.01
1011
7944
(3002030) Lymphocytes/100 leukocytes in Blood
1109
8777
1.53
20.89
5.8
5.9
%
26.8
27.6
1.95
1026
8076
(3013115) Eosinophils [#/volume] in Blood
1178
9460
1.53
20.63
5.7
5.8
e9/l
0.2
0.2
0.38
1025
8165
(3003458) Phosphate [Moles/volume] in Serum or Plasma
390
2412
1.75
20.35
5.1
5.0
mmol/l
1.0
1.0
0.27
355
2203
(3018010) Neutrophils/100 leukocytes in Blood
1090
8658
1.51
19.76
5.6
5.7
%
58.4
57.5
1.75
1013
8000
(36304419) Bacteria [Presence] in Urine
699
5048
1.56
19.66
3.6
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
878
6669
1.53
19.62
4.4
3.7
e6/l
108.5
116.7
0.11
622
4629
(3006315) Basophils [#/volume] in Blood
1138
9132
1.51
19.57
5.5
5.6
e9/l
0.0
0.0
2.31
951
7797
(3001604) Monocytes [#/volume] in Blood
1132
9094
1.51
19.23
5.5
5.6
e9/l
0.6
0.6
0.34
948
7749
(3019198) Lymphocytes [#/volume] in Blood
1154
9324
1.50
18.95
5.6
5.6
e9/l
1.8
1.9
1.33
989
8090
(3002385) Erythrocyte distribution width [Ratio]
1675
14668
1.60
18.79
25.1
18.4
%
13.8
13.8
0.39
1643
14317
(3030467) Casts [#/volume] in Urine by Automated count
714
5226
1.54
18.72
3.7
3.1
e6/l
0.4
0.5
1.88
525
3911
(3044889) 12 lead EKG panel
1521
13043
1.54
18.61
4.6
3.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
460
3059
1.64
18.08
3.1
3.1
mmol/l
0.8
0.8
5.15
429
2820
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
637
4613
1.54
17.25
2.3
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1082
8737
1.47
17.13
4.0
4.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
445
2972
1.62
17.09
3.1
2.9
e6/l
3.4
3.4
0.04
238
1566
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
532
3776
1.54
15.54
4.2
3.8
ng/l
434.1
275.2
0.26
438
3031
(3024561) Albumin [Mass/volume] in Serum or Plasma
1051
8542
1.44
15.48
4.7
4.4
g/l
34.9
35.2
0.95
979
7886
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
460
3181
1.56
15.04
1.8
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
378
2508
1.61
14.71
2.5
2.4
%
21.1
21.9
0.47
322
2114
(3026782) Osmolality of Urine
528
3793
1.52
14.43
3.1
2.8
mosm/kgh2o
522.4
526.2
0.15
441
3210
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1014
8301
1.41
13.75
2.2
2.1
pmol/l
94.1
95.7
0.49
524
3991
(3000991) Gas panel - Venous blood
245
1477
1.74
13.70
6.9
7.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1952
18112
1.70
13.58
19.1
15.0
mg/l
22.8
23.4
0.40
1680
14456
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
321
2093
1.63
13.33
2.5
2.6
umol/l
7.3
7.7
0.20
279
1793
(3004789) Transferrin [Mass/volume] in Serum or Plasma
393
2696
1.56
13.15
2.5
2.4
g/l
2.3
2.3
0.07
359
2481
(40768804) Tissue Pathology biopsy report
963
7857
1.40
13.10
2.3
2.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
451
3191
1.52
13.09
3.0
2.7
e6/l
1.1
1.5
1.16
243
1775
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
335
2224
1.60
12.89
1.8
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
421
2944
1.53
12.89
2.6
2.4
umol/l
12.2
12.6
0.26
393
2715
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
334
2219
1.60
12.81
1.8
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1860
17106
1.57
12.80
18.7
14.2
ml/min/173m2
76.5
76.2
0.25
1610
14083
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
766
6030
1.42
12.71
3.4
3.0
ng/l
1524.9
1426.4
0.29
677
5177
(3000850) Epithelial cells [#/volume] in Urine
538
3972
1.47
12.62
3.1
2.5
e6/l
6.1
6.8
0.58
460
3442
(3036481) Cortisol [Moles/volume] in Serum or Plasma
270
1718
1.65
12.32
2.1
2.1
nmol/l
354.6
372.2
0.78
252
1551
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
269
1722
1.64
11.97
2.2
2.3
u/l
31.4
37.3
1.32
227
1463
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
272
1747
1.64
11.94
3.2
2.9
ng/l
259.5
212.2
0.72
240
1601
(3018677) aPTT in Platelet poor plasma by Coagulation assay
402
2826
1.52
11.93
2.1
2.0
s
30.4
29.6
1.39
390
2728
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
267
1715
1.63
11.71
4.0
3.6
mmol/l
1.2
1.2
1.10
238
1478
(3037467) Urinalysis macro (dipstick) panel - Urine
1474
13062
1.39
11.45
5.2
4.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2010
18937
1.73
11.43
22.8
17.5
mmol/l
139.8
139.6
1.84
1981
18425
(3022217) INR in Platelet poor plasma by Coagulation assay
371
2588
1.52
11.37
31.5
25.4
inr
1.4
1.3
0.73
57
347
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
170
973
1.81
11.33
6.8
7.7
mmol/l
25.3
24.5
2.11
165
906
(3026008) Bacteria identified in Urine by Culture
847
6883
1.38
11.28
4.0
3.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1445
12778
1.38
11.26
6.0
5.1
e6/l
1885.3
2680.5
0.21
22
179
(3001122) Ferritin [Mass/volume] in Serum or Plasma
938
7751
1.37
11.23
3.3
2.8
ug/l
116.7
119.7
0.15
863
7080
(3023103) Potassium [Moles/volume] in Serum or Plasma
2011
18981
1.71
10.94
23.1
17.6
mmol/l
3.9
4.0
3.61
1979
18437
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
525
3974
1.42
10.50
3.2
3.0
mmol/l
2.5
2.5
0.19
446
3494
(3035637) Corticotropin [Mass/volume] in Plasma
55
207
2.70
10.47
1.6
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
133
723
1.89
10.44
2.6
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1163
10010
1.34
10.36
5.7
6.0
umol/l
10.8
11.1
0.48
1122
9444
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1829
16940
1.48
10.32
6.9
6.1
mmol/mol
40.5
40.1
1.22
1696
15453
(3035880) pH of Pleural fluid
35
102
3.47
10.30
1.3
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
334
2331
1.51
10.15
6.2
5.9
mmol/l
103.9
104.1
0.31
324
2284
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
89
424
2.15
10.09
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
89
424
2.15
10.09
1.2
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
62
253
2.49
10.05
1.7
1.4
g/l
33.4
32.4
0.27
57
228
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2021
19163
1.69
9.99
13.0
10.9
u/l
23.3
24.0
1.02
1981
18359
(3052851) Hemolysis interference index of Serum or Plasma
112
587
1.96
9.82
3.1
3.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
650
5152
1.37
9.79
4.6
4.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
147
844
1.79
9.71
3.5
3.4
mmol/l
24.9
24.2
1.34
140
759
(3032080) INR in Blood by Coagulation assay
924
7753
1.33
9.48
12.9
9.2
inr
1.3
1.3
1.26
272
2150
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1899
17794
1.50
9.38
5.2
4.9
mmol/l
6.0
6.0
2.68
1736
15974
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
113
605
1.91
9.31
1.6
2.3
g/l
0.0
0.0
0.11
99
554
(3016502) Oxygen saturation in Arterial blood
276
1882
1.53
9.31
6.2
6.8
%
94.5
95.6
1.17
270
1817
(3035320) C reactive protein [Mass/volume] in Body fluid
38
125
3.08
9.25
2.9
2.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
106
557
1.95
9.24
1.5
2.3
g/l
0.0
0.0
0.49
93
509
(3027801) Oxygen [Partial pressure] in Arterial blood
308
2156
1.50
9.18
6.1
6.4
kpa
11.8
12.3
0.92
300
2054
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
308
2156
1.50
9.18
6.1
6.4
kpa
5.3
5.1
2.34
302
2054
(40768806) Pleura Pathology biopsy report
51
198
2.61
9.18
2.0
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
307
2149
1.50
9.15
6.1
6.4
mmol/l
1.8
1.3
1.42
261
1692
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
620
4922
1.36
9.13
2.4
2.3
mg/l
3.1
3.1
0.06
535
4171
(3003338) MCHC [Mass/volume]
1604
14647
1.35
8.76
26.8
19.8
g/l
329.9
330.7
3.16
1591
14525
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
123
691
1.83
8.75
1.6
2.4
g/l
0.4
0.9
2.08
102
593
(3002173) Hemoglobin [Mass/volume] in Arterial blood
256
1741
1.53
8.73
6.7
7.1
g/l
120.6
118.9
0.69
249
1684
(3012441) Differential panel - Pleural fluid
49
192
2.59
8.67
1.9
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
103
550
1.92
8.58
1.5
2.3
g/l
0.0
0.0
0.00
93
508
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
190
1219
1.61
8.35
1.8
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1925
18173
1.48
8.28
5.5
5.2
mmol/l
2.7
2.7
2.96
1782
16433
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
298
2115
1.47
8.26
4.0
3.9
u/l
236.0
248.0
0.80
273
1983
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
114
638
1.83
8.22
1.5
2.2
g/l
36.5
37.5
1.25
93
535
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
37
131
2.86
7.96
1.5
1.2
u/l
11.6
10.5
0.34
37
115
(3042936) Bacteria identified in Isolate by Culture
358
2650
1.42
7.91
2.1
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
440
3374
1.38
7.91
1.4
1.4
g/l
2.3
2.4
0.78
240
1921
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
112
632
1.81
7.88
1.6
3.3
mg/l
131.6
51.1
0.37
98
518
(3034860) Kappa light chains.free [Mass/volume] in Serum
111
631
1.80
7.63
1.7
3.3
mg/l
46.2
159.2
0.68
97
517
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
42
164
2.59
7.53
1.5
1.3
u/l
412.8
295.6
0.36
42
157
(3024731) MCV [Entitic volume]
2059
19787
1.65
7.49
29.9
22.3
fl
91.1
91.4
2.52
2040
19451
(3035941) MCH [Entitic mass]
2059
19789
1.65
7.46
29.9
22.3
pg
30.1
30.3
4.50
2040
19452
(3026361) Erythrocytes [#/volume] in Blood
2059
19790
1.65
7.45
30.0
22.4
e12/l
4.4
4.4
7.48
2011
19161
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
153
958
1.64
7.43
7.6
8.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2059
19793
1.65
7.41
30.1
22.4
e9/l
6.8
6.7
1.17
2014
19159
(3000963) Hemoglobin [Mass/volume] in Blood
2059
19794
1.65
7.39
30.2
22.5
g/l
132.8
131.8
2.60
2041
19463
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
34
120
2.86
7.38
1.6
1.5
u/l
11.7
13.6
1.07
34
111
(3007461) Platelets [#/volume] in Blood
2058
19784
1.64
7.36
30.0
22.4
e9/l
255.6
254.8
0.23
2019
19222
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
78
400
1.99
7.35
1.5
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
237
1644
1.50
7.35
2.2
2.6
g/l
64.1
66.4
4.72
208
1473
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
108
618
1.79
7.27
1.6
3.2
ratio
1.9
1.7
—
9
54
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
126
754
1.71
7.26
1.7
2.4
g/l
3.3
3.1
1.08
96
581
(3002032) Base excess in Venous blood by calculation
245
1719
1.48
7.18
3.9
3.3
mmol/l
2.5
2.0
0.94
213
1416
(3009542) Hematocrit [Volume Fraction] of Blood
1710
15923
1.33
7.11
23.1
16.4
%
38.8
38.4
0.90
1238
10532
(3023199) Leukocytes [#/volume] in Pleural fluid
53
237
2.27
7.11
1.8
1.4
e6/l
1652.2
1618.1
0.03
37
170
(3014111) Lactate [Moles/volume] in Serum or Plasma
231
1606
1.49
7.08
6.0
5.7
mmol/l
1.2
1.3
2.65
226
1545
(3020779) Urea [Moles/volume] in Serum or Plasma
228
1585
1.49
6.99
7.3
6.6
mmol/l
10.9
9.9
0.98
213
1514
(3027456) Digoxin [Moles/volume] in Serum or Plasma
90
495
1.85
6.91
3.3
3.3
nmol/l
0.8
0.8
0.13
73
387
(3028308) Erythrocytes [#/volume] in Pleural fluid
48
209
2.33
6.85
1.8
1.3
e6/l
24823.6
87748.8
0.92
27
115
(3021447) Carbon dioxide [Partial pressure] in Venous blood
244
1732
1.46
6.74
3.9
3.3
kpa
6.0
5.8
1.36
238
1685
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
207
1422
1.50
6.73
1.6
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
44
187
2.38
6.64
2.0
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1117
9901
1.26
6.61
2.9
2.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
587
4808
1.30
6.61
1.7
1.6
nmol/l
19.8
21.3
1.72
514
4015
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
33
122
2.73
6.61
1.2
1.1
titre
284.0
111.5
—
5
20
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
121
744
1.66
6.34
1.6
2.3
g/l
9.7
10.2
0.77
98
624
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
683
5731
1.28
6.33
3.3
3.1
u/l
30.0
35.5
1.47
647
5421
(3002256) Pathology report gross observation
324
2446
1.38
6.32
1.3
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
490
3939
1.31
6.30
1.3
1.3
u/ml
1.4
1.5
0.04
108
1004
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1799
16958
1.34
6.28
4.2
4.1
mmol/l
1.3
1.3
0.01
1638
15156
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
128
803
1.63
6.20
1.7
2.3
g/l
3.7
3.7
0.08
96
564
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
128
804
1.63
6.18
1.7
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
128
804
1.63
6.18
1.7
2.3
g/l
7.7
7.5
0.43
97
592
(3020682) Albumin/Creatinine [Ratio] in Urine
709
5993
1.27
6.15
4.0
3.8
mg/mmol
10.5
8.5
0.39
430
3522
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1869
17740
1.36
6.06
4.8
4.6
mmol/l
4.6
4.7
5.85
1736
16117
(3003694) ABO and Rh group [Type] in Blood
548
4495
1.29
6.03
1.4
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1947
18608
1.41
6.02
18.4
14.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
31
117
2.67
5.99
1.2
1.2
u/l
34.0
16.7
0.60
26
100
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
102
610
1.70
5.94
2.4
2.7
u/ml
0.4
0.4
0.11
60
356
(3009508) Creatinine [Moles/volume] in Urine
692
5855
1.27
5.91
3.2
3.0
mmol/l
6.5
6.6
0.35
553
4829
(3026493) Urate [Moles/volume] in Serum or Plasma
568
4691
1.28
5.91
2.9
2.6
umol/l
4750.3
6075.6
0.28
473
3975
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
55
270
2.06
5.90
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
78
432
1.84
5.90
1.2
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
272
2017
1.40
5.90
3.5
3.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
506
4121
1.30
5.86
1.9
1.7
mg/l
1.3
1.2
0.36
398
3188
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
706
5994
1.26
5.84
2.5
2.4
u/l
56.8
57.8
0.26
664
5476
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
46
212
2.19
5.80
1.2
1.2
u/l
71.8
53.7
0.95
36
142
(3012516) Albumin [Mass/volume] in Urine
671
5670
1.26
5.77
3.3
3.1
mg/l
353.5
347.0
0.01
421
3339
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
850
7390
1.25
5.67
4.2
3.8
ng/l
112.4
101.2
0.04
599
5288
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1852
17593
1.34
5.66
4.7
4.6
mmol/l
1.5
1.5
6.16
1697
15882
(3027945) Reticulocytes/100 erythrocytes in Blood
287
2180
1.36
5.37
2.5
2.5
%
1.9
1.8
0.14
254
1909
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
51
257
2.01
5.14
1.2
1.2
nmol/l
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
67
371
1.83
5.12
1.6
1.6
mu/l
252.2
315.0
1.63
62
333
(3000492) Spirometry study
211
1536
1.41
5.10
1.5
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
167
1166
1.47
5.05
7.9
7.4
%
92.8
93.8
0.71
167
1160
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
185
2542
0.70
4.99
8.3
7.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1223
11142
1.22
4.98
3.3
3.1
u/l
44.3
48.0
0.90
1152
10155
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
61
331
1.87
4.97
1.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1029
9225
1.22
4.89
5.9
5.5
estimate
0.0
0.0
0.50
194
1659
(3011985) Renin [Units/volume] in Plasma
49
250
1.98
4.80
1.5
1.4
mu/l
101.1
40.8
0.97
39
226
(3035350) Ketones [Presence] in Urine by Test strip
1021
9162
1.21
4.76
4.2
4.1
estimate
0.0
0.0
0.00
189
1666
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
47
237
2.00
4.76
1.3
1.4
pmol/l
337.3
291.5
0.27
34
182
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
164
1160
1.45
4.65
8.0
7.4
%
0.6
0.7
0.69
164
1151
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
593
5054
1.24
4.55
1.7
1.6
mmol/l
1.4
1.3
0.31
483
4219
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
84
518
1.65
4.44
1.8
1.6
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
19
65
2.94
4.44
1.4
1.5
ug/l
0.3
0.5
0.60
12
37
(3009261) Glucose [Presence] in Urine by Test strip
1034
9330
1.20
4.44
4.3
4.1
estimate
0.0
0.0
0.00
183
1660
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
128
871
1.50
4.43
1.5
1.7
g/l
1.7
1.6
0.85
108
746
(3004588) Protein electrophoresis panel - Serum or Plasma
189
1386
1.40
4.40
1.7
2.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
13
36
3.63
4.20
2.5
1.4
ng/l
114.2
88.2
0.34
13
36
(3007853) Bacteria identified in Skin by Aerobe culture
267
2092
1.31
4.06
2.0
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
37
182
2.05
4.05
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
74
459
1.63
3.87
1.6
3.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
334
2719
1.27
3.79
1.3
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
303
2443
1.28
3.71
1.3
1.3
titre
439.4
572.2
0.74
68
552
(3044941) Cell count panel - Synovial fluid
53
310
1.73
3.48
1.7
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
58
349
1.68
3.44
1.9
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
184
1402
1.34
3.42
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
276
2224
1.28
3.40
3.0
3.9
ug/l
4.5
18.1
2.77
223
1802
(3024928) Oxygen saturation in Venous blood
62
381
1.65
3.40
2.2
2.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
442
3772
1.22
3.24
4.2
4.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
671
5957
1.18
3.19
2.1
2.1
u/l
178.6
207.8
0.41
631
5538
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
25
117
2.15
3.16
1.6
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
189
1469
1.31
3.08
3.6
3.1
ug/l
0.7
0.8
2.31
142
1008
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
105
745
1.43
3.03
1.9
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
77
516
1.51
2.96
1.5
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
456
3939
1.20
2.93
1.8
1.8
nmol/l
1121.4
1187.0
0.76
364
2895
(3009214) Lutropin [Units/volume] in Serum or Plasma
42
244
1.74
2.87
1.1
1.2
u/l
16.9
14.5
0.38
35
190
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
104
745
1.42
2.86
2.9
3.1
u/ml
286.5
2121.8
0.74
86
627
(1616796) Gas panel - Central venous blood
60
384
1.58
2.84
2.5
3.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
122
1620
0.74
2.72
4.2
3.7
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
14
54
2.60
2.70
1.1
1.2
%
120.2
115.4
0.43
14
45
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
87
612
1.44
2.66
2.6
2.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
205
1648
1.27
2.61
2.4
2.5
e9/l
72.6
70.4
0.38
153
1258
(3019060) Gas panel - Arterial blood
160
1246
1.31
2.61
4.0
4.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
79
548
1.46
2.61
1.4
1.6
g/l
1.1
1.2
0.57
73
520
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
115
2.01
2.51
1.9
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
42
255
1.66
2.49
1.1
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
541
4805
1.17
2.48
4.3
3.8
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
26
3.47
2.48
1.4
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
109
809
1.37
2.47
2.0
1.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
145
1125
1.31
2.45
1.6
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
76
531
1.45
2.44
1.3
1.6
g/l
0.2
0.2
0.23
70
505
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
30
168
1.80
2.37
1.1
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
17
4.13
2.36
10.1
15.9
mmol/l
5.0
5.6
—
7
17
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
13
52
2.51
2.36
1.2
1.3
ug/l
28.1
515.7
—
5
32
(3025159) Blasts/100 leukocytes in Blood
178
1427
1.27
2.34
4.3
4.1
%
0.0
0.3
0.69
40
338
(3006184) Hemoglobin [Mass/volume] in Capillary blood
59
396
1.50
2.32
2.0
2.0
g/l
132.0
126.7
0.86
38
281
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
58
389
1.50
2.29
1.7
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
580
0.61
2.25
1.4
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
59
399
1.49
2.25
1.2
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
208
2514
0.81
2.23
4.7
4.7
%
33.1
33.6
0.24
155
1585
(3021440) Promyelocytes/100 leukocytes in Blood
187
1518
1.25
2.23
4.3
4.0
%
0.0
0.1
1.60
50
399
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
224
1857
1.23
2.21
2.1
2.1
g/l
0.2
0.2
0.22
209
1734
(3012501) Base excess in Blood by calculation
60
410
1.48
2.18
3.5
4.2
mmol/l
3.0
3.0
0.01
51
288
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
39
242
1.62
2.16
1.6
1.5
%
44.9
59.2
1.13
26
154
(3011397) Hemoglobin [Presence] in Urine by Test strip
501
4475
1.15
2.11
3.7
4.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
71
506
1.42
2.09
2.0
2.1
nmol/l
10.3
11.1
0.35
61
432
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
31
2.91
2.07
1.1
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
67
476
1.42
2.01
1.9
1.7
e6/l
12943.0
13778.2
0.07
49
348
(3019977) pH of Arterial blood
18
90
2.01
2.00
2.2
3.2
ph
7.4
7.4
—
8
28
(3051611) Lipemic interference index of Serum or Plasma
36
224
1.62
2.00
2.9
3.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
82
605
1.37
1.99
1.2
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
482
4317
1.15
1.95
1.8
1.7
pmol/l
57357036.3
24463346.4
0.47
401
3491
(3017569) Oxygen content in Arterial blood
18
91
1.99
1.95
2.3
2.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
192
1589
1.23
1.95
4.3
4.0
%
1.2
0.9
0.47
52
434
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
11
4.55
1.94
1.2
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
83
617
1.36
1.93
3.1
2.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
21
113
1.87
1.91
2.3
3.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
22
3.19
1.88
1.0
1.8
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
22
3.19
1.88
2.6
2.8
u/field
1.3
0.7
—
7
22
(3016650) Hepatitis A virus Ab [Presence] in Serum
38
244
1.57
1.87
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
70
511
1.38
1.83
1.5
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
299
2596
1.18
1.83
1.5
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
22
123
1.80
1.80
1.0
1.0
mg/l
299.0
294.4
0.12
22
102
(3007566) Smooth muscle Ab [Titer] in Serum
64
462
1.40
1.79
1.2
1.2
titre
67.1
83.6
—
7
25
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
123
978
1.27
1.79
1.7
1.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
8
29
2.76
1.79
1.6
1.7
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
18
3.34
1.74
2.3
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
36
2.51
1.74
1.1
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
85
646
1.33
1.74
2.2
2.2
ug/l
304.0
782.3
0.83
74
603
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
38
249
1.54
1.73
1.1
1.1
—
—
—
0
0
(3010421) pH of Blood
68
500
1.37
1.72
3.4
4.0
ph
7.4
7.4
1.04
58
402
(3028026) IgM [Mass/volume] in Serum or Plasma
129
1038
1.26
1.71
1.5
1.7
g/l
1.3
1.5
0.68
121
935
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
22
126
1.75
1.68
1.2
1.2
titre
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
22
126
1.75
1.68
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
55
392
1.41
1.67
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
182
1531
1.21
1.61
1.7
1.7
%
1.5
1.4
0.26
151
1307
(4281824)
39
262
1.50
1.61
1.2
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
238
2054
1.18
1.58
4.6
4.5
%
20.4
21.4
0.52
117
1037
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
16
85
1.89
1.55
1.1
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
59
433
1.37
1.54
2.4
3.1
mg/l
1.8
1.6
0.96
53
398
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
18
100
1.81
1.53
2.1
1.8
u/field
1.5
2.8
0.66
12
71
(3044242) Glucose [Moles/volume] in Arterial blood
18
100
1.81
1.53
2.2
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
27
169
1.61
1.52
1.0
1.2
—
—
—
0
0
(4035726)
212
1821
1.18
1.50
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
108
868
1.26
1.48
1.6
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
24
147
1.64
1.47
1.7
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
182
1547
1.19
1.46
4.5
4.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
22
132
1.67
1.46
1.8
1.6
u/l
4.0
6.4
0.57
14
58
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
200
1717
1.18
1.44
2.5
2.4
ug/l
5.3
6.3
0.44
176
1452
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
111
900
1.25
1.42
1.0
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
132
1091
1.22
1.42
1.2
1.3
au/ml
79.3
44.9
—
6
50
(3017732) Neutrophils [#/volume] in Blood
147
1230
1.21
1.40
2.2
3.1
e9/l
4.3
4.0
0.99
112
906
(3034426) Prothrombin time (PT)
10
46
2.18
1.40
1.5
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
290
2573
1.15
1.37
5.7
5.3
ug/l
3.8
3.4
0.15
246
2246
(3004809) Band form neutrophils/100 leukocytes in Blood
43
306
1.41
1.36
5.0
3.5
%
1.0
1.3
0.36
32
238
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
57
426
1.35
1.36
1.4
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
240
2102
1.16
1.35
1.9
2.0
ug/g
155.1
136.5
0.29
196
1604
(3022145) Colonoscopy Study observation
239
2095
1.16
1.34
1.3
1.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
13
68
1.92
1.33
1.1
3.1
umol/l
57.7
181.8
—
6
43
(3000494) Fungus identified in Specimen by Culture
250
2203
1.15
1.30
1.3
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
72
561
1.29
1.30
4.4
6.6
mmol/l
1.3
1.3
0.04
63
498
(3028626) Oxygen [Partial pressure] in Capillary blood
53
396
1.35
1.28
2.5
2.7
kpa
8.2
8.0
0.26
47
362
(3022689) Creatine [Moles/volume] in Urine
10
48
2.09
1.27
1.1
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
17
99
1.72
1.27
2.9
1.8
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
15
84
1.79
1.27
1.2
1.9
e9/l
0.2
0.2
—
10
73
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
35
2.29
1.27
1.4
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
23
146
1.58
1.26
1.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
119
988
1.22
1.25
1.3
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
75
591
1.28
1.25
1.3
1.4
ug/g
296.0
286.4
0.14
41
335
(40768443) Skin Pathology biopsy report
107
881
1.23
1.23
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
741
6973
1.09
1.22
4.5
4.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
48
356
1.36
1.22
1.6
2.7
umol/l
30.5
34.7
0.47
32
298
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
19
2.64
1.21
1.2
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
143
1216
1.19
1.18
2.3
2.4
au/ml
20.1
27.4
—
6
53
(40768793) Breast Pathology biopsy report
49
646
0.75
1.17
1.2
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
32
223
1.44
1.16
1.5
1.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
234
2073
1.14
1.15
1.6
1.6
—
—
—
0
0
(4094501)
61
474
1.30
1.15
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
19
118
1.62
1.15
1.4
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
14
234
0.60
1.13
1.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
119
1.60
1.11
1.4
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
152
1308
1.17
1.11
2.3
2.7
g/l
9.7
10.5
1.35
138
1182
(3009343) pH of Capillary blood
134
1141
1.19
1.11
4.0
3.7
ph
7.4
7.4
1.40
18
134
(3011648) Oxygen content in Venous blood
21
136
1.55
1.08
1.7
1.6
%
12.0
10.6
0.68
21
136
(3008152) Bicarbonate [Moles/volume] in Arterial blood
138
1181
1.18
1.08
6.7
6.6
mmol/l
25.1
24.6
1.16
131
1101
(3022621) pH of Urine by Test strip
154
1330
1.17
1.08
3.8
3.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
61
479
1.28
1.08
2.2
2.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
15
89
1.69
1.07
1.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
15
89
1.69
1.07
1.4
1.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
10
52
1.93
1.06
47.7
28.2
ug/l
8.3
7.5
—
10
46
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
27
186
1.46
1.06
1.5
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
208
1841
1.14
1.05
1.5
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
129
1.56
1.05
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
118
999
1.19
1.05
1.2
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
93
770
1.22
1.04
1.6
1.9
u/l
36.0
39.3
0.94
83
676
(4010399)
154
1335
1.17
1.04
1.4
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
24
162
1.49
1.04
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
178
1561
1.15
1.03
1.5
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
22
2.28
1.03
2.4
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
71
572
1.25
1.03
1.3
1.3
iu/l
40.9
33.6
0.91
65
487
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
26
179
1.46
1.03
1.7
1.4
%
28.0
33.3
0.25
17
112
(1761868) Lipid panel - Serum or Plasma
595
5591
1.09
1.00
3.2
3.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
69
556
1.25
1.00
1.2
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
15
91
1.65
1.00
1.7
1.3
%
6.7
5.3
—
6
18
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
35
2.00
1.00
1.1
1.1
—
—
—
0
0
(3013512) EKG study
623
5869
1.09
0.99
4.6
4.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
134
1156
1.17
0.97
4.0
3.7
kpa
5.3
5.2
0.75
125
1062
(3038177) Helicobacter pylori Ab [Presence] in Serum
35
258
1.36
0.97
1.2
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
50
1.80
0.96
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
53
416
1.28
0.96
2.1
2.3
ug/min
47.3
101.6
1.41
31
238
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
68
551
1.24
0.95
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
69
562
1.24
0.93
1.2
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
33
243
1.36
0.93
1.4
1.4
u/ml
104.8
110.5
—
6
49
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
6
28
2.15
0.91
1.5
1.2
u/l
28.3
1444.5
—
6
17
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
151
1323
1.15
0.91
3.0
3.6
u/ml
115.5
60.8
0.28
146
1275
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
39
296
1.32
0.91
5.8
4.8
iu/ml
336.5
325.6
—
6
39
(1002224) Polysomnography panel
69
564
1.23
0.90
1.2
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
29
2.07
0.89
3.3
4.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
42
1.91
0.88
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
63
512
1.24
0.88
1.1
1.2
—
34.0
—
0
36
(3005322) IgE [Units/volume] in Serum or Plasma
126
1093
1.16
0.88
1.3
1.2
u/ml
154.5
184.4
0.27
116
995
(3021901) Oxygen saturation in Capillary blood
42
325
1.30
0.86
2.6
2.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
32
238
1.35
0.86
1.0
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
105
901
1.17
0.84
2.8
2.4
%
1.2
1.1
0.24
105
895
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
52
416
1.26
0.84
1.2
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
57
1.76
0.83
1.6
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
60
489
1.23
0.82
1.4
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
36
275
1.31
0.82
1.6
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
126
1100
1.15
0.82
4.0
3.7
mmol/l
2.7
2.0
1.10
104
828
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
25
180
1.39
0.82
2.0
2.3
u/field
3.1
2.1
0.41
13
61
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
14
89
1.58
0.81
1.4
1.4
mmol/l
6.0
6.0
0.04
14
84
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14
89
1.58
0.81
1.2
1.9
e6/l
518.1
452.0
—
9
74
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
24
172
1.40
0.81
1.4
1.6
nmol/l
45.5
43.8
0.10
24
162
(3000330) Specific gravity of Urine by Test strip
126
1102
1.15
0.80
3.9
3.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
63
519
1.22
0.79
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
28
207
1.36
0.79
1.3
1.3
mosm/kgh2o
278.7
275.7
0.34
23
152
(21491868) Cryoglobulin [Mass/volume] in Serum
12
74
1.63
0.78
1.3
1.3
g/l
—
0.4
—
0
6
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
32
243
1.32
0.77
1.2
1.2
u/ml
294.1
267.4
0.25
23
147
(3036603) Volume of Urine
19
132
1.44
0.76
1.3
1.4
ml
2022.8
1678.9
—
5
28
(4211845)
15
99
1.52
0.75
4.3
4.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
147
1307
1.13
0.75
1.3
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
335
3113
1.09
0.75
1.3
1.2
u/ml
13.2
13.7
0.04
112
1148
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
262
1.30
0.74
1.1
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
22
158
1.40
0.74
2.2
2.9
mg/l
40.8
17.2
0.45
12
112
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
29
219
1.33
0.73
1.6
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
56
1.61
0.72
1.2
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
14
92
1.53
0.72
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
14
92
1.53
0.72
4.1
4.4
—
—
—
0
0
(4024509)
29
220
1.32
0.71
1.3
1.7
—
—
—
0
0
(3019225) pH of Specimen
232
2126
1.10
0.71
5.7
4.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
23
169
1.36
0.69
1.4
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
161
1449
1.12
0.69
4.0
3.8
%
0.6
0.5
0.21
32
304
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
27
204
1.33
0.69
3.2
3.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
30
231
1.30
0.67
1.2
1.2
u/ml
8.0
1.7
0.60
11
61
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
62
521
1.20
0.67
1.5
1.5
iu/ml
0.0
11.0
0.51
16
111
(3015235) Bicarbonate [Moles/volume] in Capillary blood
55
457
1.21
0.66
3.0
3.0
mmol/l
26.0
25.2
0.59
50
393
(3043238) Trisomy 21 risk [Likelihood] in Fetus
22
162
1.36
0.66
1.6
1.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
28
1.79
0.66
1.0
1.2
umol/24h
2.0
1.7
—
5
28
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
133
1485
0.89
0.65
2.5
2.6
ml/min/173m2
57.4
63.3
1.50
66
624
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
41
331
1.24
0.65
2.6
1.8
nmol/l
1.0
0.8
0.75
34
268
(44816559) Phosphatidylethanol [Mass/volume] in Blood
33
260
1.27
0.64
1.1
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
45
369
1.22
0.63
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
349
3277
1.08
0.62
1.3
1.3
iu/ml
33.4
38.1
0.26
98
1038
(3020491) Glucose [Moles/volume] in Blood
19
138
1.38
0.62
1.7
2.6
mmol/l
6.7
7.0
0.36
19
90
(3022313) Gas panel - Capillary blood
96
843
1.15
0.62
4.3
3.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
49
1.63
0.62
2.5
3.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
49
1.63
0.62
2.5
3.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
8
49
1.63
0.62
1.4
1.4
%
24.8
23.6
—
8
39
(3001186) Copper [Moles/volume] in Serum or Plasma
5
30
1.67
0.61
1.2
1.2
umol/l
17.7
18.1
—
5
25
(3000012) Reticulocyte production index
16
113
1.42
0.61
1.8
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
21
156
1.35
0.61
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
199
1827
1.10
0.61
1.7
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
53
444
1.20
0.60
1.7
1.8
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
0.5
—
0
13
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.1
—
64.9
—
0
13
(3010144) Erythrocytes [#/volume] in Synovial fluid
25
192
1.31
0.59
1.3
1.3
e6/l
211286.1
108110.3
0.27
19
128
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
30
377
0.79
0.59
1.3
1.3
miu/ml
170.2
231.8
0.60
13
167
(3047352) Trisomy 18 risk [Likelihood] in Fetus
21
157
1.34
0.59
1.5
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
30
237
1.27
0.58
1.1
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
23
175
1.32
0.58
1.5
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
150
0.67
0.58
1.5
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
89
1.46
0.58
1.0
1.0
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
15
106
1.42
0.57
1.2
1.1
u/l
81.1
76.7
—
10
83
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
21
158
1.33
0.57
1.0
1.2
%
87.1
96.1
0.94
21
148
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
81
1.48
0.57
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
73
1.51
0.56
2.0
2.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
46
384
1.20
0.56
2.3
2.4
%
17.1
15.9
1.10
23
186
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
26
203
1.28
0.55
1.6
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
90
1.45
0.55
1.1
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
15
107
1.40
0.55
1.2
1.1
u/l
19.7
24.4
—
9
82
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
6
38
1.58
0.54
1.7
1.2
mg/l
1.5
121.4
—
6
29
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
38
1.58
0.54
2.8
2.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
63
543
1.16
0.54
2.0
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
28
222
1.26
0.54
1.1
1.1
u/ml
1.8
2.1
—
10
80
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
44
369
1.20
0.52
3.2
3.6
%
60.9
57.6
1.25
44
369
(3027273) Bicarbonate [Moles/volume] in Venous blood
104
935
1.12
0.50
4.5
3.2
mmol/l
26.2
25.5
1.76
99
910
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
67
1.49
0.49
3.7
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
30
243
1.24
0.49
1.8
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
110
1.37
0.48
1.3
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
110
1.37
0.48
1.3
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
154
1.30
0.48
1.2
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
79
700
1.13
0.48
1.6
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
235
1.24
0.48
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
76
1.45
0.48
1.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
10
143
0.70
0.47
1.3
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
17
128
1.33
0.47
1.8
2.0
umol/l
6.5
7.5
0.16
17
82
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
47
1.49
0.47
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
85
1.41
0.47
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
85
1.41
0.47
1.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
48
1.46
0.46
1.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
49
1.43
0.46
1.0
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
14
103
1.36
0.45
2.3
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
69
1.45
0.44
3.2
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
27
220
1.23
0.43
1.1
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
163
0.73
0.43
1.1
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
163
0.73
0.43
1.1
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
163
0.73
0.43
1.1
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
26
211
1.24
0.43
1.3
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
56
1.43
0.42
1.8
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
28
230
1.22
0.42
1.2
1.2
u/ml
3.8
5.6
0.42
16
88
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
91
0.66
0.42
1.0
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
55
481
1.15
0.42
1.1
1.2
u/ml
3.6
6.4
—
8
96
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
13
96
1.36
0.41
1.2
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
89
983
0.90
0.41
1.3
1.4
—
—
—
0
0
(4133840)
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.3
—
51.3
—
0
8
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
16
0.00
0.41
0.0
2.5
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.3
—
165.4
—
0
5
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
123
1.30
0.40
1.2
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
76
682
1.12
0.40
4.4
3.5
mmol/l
1.5
1.4
0.45
76
668
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
250
1.20
0.40
1.3
1.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
20
159
1.26
0.40
1.1
1.1
—
62.9
—
0
8
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
19
150
1.27
0.40
1.0
1.1
—
2.3
—
0
12
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
9.3
—
0
18
(3003181) Sodium [Moles/volume] in Urine
45
390
1.16
0.39
1.5
1.3
mmol/l
58.5
59.4
0.05
30
315
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
101
0.69
0.39
1.0
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
101
0.69
0.39
1.0
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
101
0.69
0.39
1.0
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
101
0.69
0.39
1.0
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
101
0.69
0.39
1.1
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
13
97
1.34
0.39
3.2
2.2
—
188.6
—
0
17
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
19
0.00
0.39
0.0
4.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
53
466
1.14
0.39
1.1
1.1
u/ml
5.8
7.1
—
7
41
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
119
1097
1.09
0.38
1.9
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
159
0.75
0.38
1.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
36
1.39
0.38
1.0
1.3
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
9
67
1.34
0.38
1.1
1.5
umol/l
2.1
2.1
—
9
61
(3045424) Erythrocytes [Presence] in Urine
26
312
0.83
0.38
1.5
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
234
1.20
0.37
1.0
1.1
u/ml
0.5
1.2
—
9
85
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
69
1.31
0.37
2.2
2.6
u/ml
789.6
1218.9
—
9
69
(3052592) Norovirus Ag [Presence] in Stool
5
37
1.35
0.37
1.2
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
115
0.69
0.37
1.1
1.4
promille
1.4
1.1
—
8
87
(3039443) Prostate specific Ag panel - Serum or Plasma
8
116
0.69
0.37
1.9
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
72
1.39
0.37
1.0
1.2
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
6
43
1.40
0.35
1.3
1.4
g/l
21.2
31.4
—
6
30
(1761482) Bacteria [#/volume] in Urine by Culture
64
576
1.11
0.34
5.1
4.9
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
136
1.25
0.33
1.7
1.2
u/ml
0.6
1.4
—
10
61
(3038026) Centromere Ab [Units/volume] in Serum
20
164
1.22
0.32
1.1
1.1
—
66.9
—
0
8
(3023419) Bacteria identified in Sputum by Culture
28
238
1.18
0.32
1.8
2.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
355
3418
1.05
0.32
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
192
1.20
0.32
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
192
1.20
0.32
1.5
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
506
4913
1.04
0.31
4.5
4.5
estimate
0.0
0.0
0.80
191
1638
(40768795) Lymph node Pathology biopsy report
16
197
0.81
0.31
1.2
1.2
—
—
—
0
0
(44813793)
10
131
0.76
0.30
1.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
193
1.19
0.30
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
193
1.19
0.30
1.5
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
99
0.71
0.30
6.1
12.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
25
212
1.18
0.30
7.0
6.1
mg/l
12.5
12.2
0.12
25
198
(3045414) Leukocytes [Presence] in Urine
95
880
1.08
0.30
2.2
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
141
0.78
0.29
1.5
1.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
41
461
0.89
0.29
4.5
3.2
mmol/l
7.9
7.7
0.28
41
452
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
206
0.82
0.29
5.3
3.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
92
853
1.08
0.29
1.5
1.5
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
16
130
1.23
0.28
1.4
1.2
mmol/l
2.5
2.2
0.44
16
124
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
184
0.81
0.28
1.2
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
61
555
1.10
0.28
2.0
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
48
431
1.12
0.28
1.6
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
103
1.26
0.28
1.2
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
140
0.78
0.28
1.1
1.0
u/ml
0.7
5.3
—
5
46
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
34
386
0.88
0.28
1.4
1.3
e6/l
162.4
24.5
0.40
25
290
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
34
386
0.88
0.28
1.4
1.4
e6/l
294.4
931.5
0.98
28
310
(3009466) Valproate [Moles/volume] in Serum or Plasma
21
248
0.85
0.28
5.9
4.9
umol/l
378.4
364.6
0.20
16
213
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
79
730
1.09
0.27
4.7
4.1
mmol/l
25.7
25.1
0.94
74
670
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
131
1.22
0.27
2.4
2.5
—
—
—
0
0
(44806420)
8
65
1.23
0.27
3.6
2.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
236
0.85
0.26
1.2
1.4
—
—
—
0
0
(44790049)
16
193
0.83
0.26
1.4
1.4
—
—
—
0
0
(44790048)
16
193
0.83
0.26
1.4
1.4
—
—
—
0
0
(44806118)
16
193
0.83
0.26
1.4
1.4
—
—
—
0
0
(44790047)
16
193
0.83
0.26
1.4
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
8
67
1.19
0.26
2.0
2.0
ug/l
21.1
133.3
—
8
60
(3003888) Timothy IgE Ab [Units/volume] in Serum
24
206
1.17
0.26
1.0
1.0
u/ml
1.5
2.9
0.66
11
91
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
73
0.68
0.26
1.2
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
40
446
0.89
0.25
1.3
1.2
mg/l
676.4
522.7
1.01
40
421
(3002523) Influenza virus A Ag [Presence] in Specimen
22
188
1.17
0.25
1.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
148
0.81
0.24
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
96
1.25
0.24
1.0
1.2
—
—
—
0
0
(4306422)
25
217
1.15
0.24
1.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
77
1.17
0.24
1.2
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
126
0.79
0.24
1.4
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
84
0.71
0.24
1.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
84
0.71
0.24
1.0
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
85
0.71
0.24
1.0
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
199
1.16
0.23
1.0
1.0
u/ml
1.8
1.6
—
10
76
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
92
0.76
0.22
1.4
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
18
153
1.18
0.22
1.2
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
34
305
1.12
0.21
1.8
1.9
u/l
5006.6
2526.0
0.42
15
123
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
2.6
—
0
6
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
0.4
—
0
5
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.0
—
0
5
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
7.8
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
13.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
40
440
0.91
0.21
4.7
3.8
mg/l
23.4
26.0
0.17
24
278
(40758358) Immune stain study
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
12
0.00
0.21
0.0
1.3
—
22.6
—
0
5
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
6
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
15
177
0.85
0.21
1.8
1.5
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.0
—
7.2
—
0
13
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.0
—
38.0
—
0
13
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
0.9
—
0
8
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.0
—
0
6
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.0
—
20.7
—
0
13
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.0
—
0
8
(3011897) Casein IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
198
0.86
0.20
1.2
1.4
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.0
—
0
9
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.0
—
0
9
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.4
—
16.6
—
0
8
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
136
1.18
0.20
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
77
723
1.07
0.20
1.7
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
50
1.20
0.19
1.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
50
1.20
0.19
1.2
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
51
1.18
0.19
1.2
1.1
miu/ml
1214.7
1766.2
—
6
51
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
52
1.15
0.19
1.7
1.4
ug/l
7.1
8.8
—
6
52
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
10
81
1.24
0.18
1.4
1.5
—
1.5
—
0
6
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
6
53
1.13
0.18
1.0
1.2
%
—
10.9
—
0
8
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
28
251
1.12
0.18
1.4
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
19
217
0.87
0.18
1.4
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
88
834
1.06
0.18
1.3
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
412
4034
1.03
0.17
4.9
4.6
kg/l
1.0
1.0
0.18
81
615
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
24
214
1.12
0.17
1.1
1.1
%
118.6
118.9
0.02
24
194
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
16
138
1.16
0.17
1.1
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
63
1.11
0.17
1.4
2.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
67
0.75
0.17
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
162
0.86
0.16
1.2
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
283
1.10
0.16
1.1
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
73
1.10
0.15
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
17
193
0.88
0.15
1.7
1.9
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
53
565
0.94
0.15
1.4
1.5
pmol/l
98.6
244.2
3.18
53
552
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
245
0.90
0.15
1.1
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
45
420
1.07
0.14
2.2
3.1
u/ml
220.7
1001.3
0.63
39
379
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
192
0.88
0.14
2.4
2.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
21
188
1.12
0.14
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
52
553
0.94
0.14
1.5
1.7
mg/l
3.4
3.9
0.13
39
403
(3028271) Lactate [Moles/volume] in Capillary blood
33
304
1.09
0.14
1.7
1.9
mmol/l
1.7
1.6
0.13
33
295
(3044290) Cell count panel - Cerebral spinal fluid
38
353
1.08
0.14
1.2
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
122
1.15
0.13
1.4
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
115
1108
1.04
0.13
1.3
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
24
219
1.10
0.12
1.1
1.2
—
—
—
0
0
(4146454)
21
231
0.91
0.12
2.9
2.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
272
0.92
0.12
1.2
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
70
732
0.95
0.12
1.9
1.9
ug/l
0.7
1.9
1.62
57
629
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
220
1.09
0.11
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
95
1.16
0.11
6.4
3.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
19
172
1.11
0.11
1.5
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
105
1.14
0.11
1.4
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
86
1.16
0.11
1.0
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
115
1115
1.03
0.11
2.5
2.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
69
662
1.04
0.10
2.8
2.9
g/l
0.3
0.3
0.03
32
235
(3024980) IgG subclass 4 [Mass/volume] in Serum
27
251
1.08
0.10
1.9
1.7
g/l
0.7
0.8
0.20
19
192
(4062490)
17
154
1.10
0.10
1.9
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
41
388
1.06
0.10
1.1
1.2
—
10.8
—
0
5
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
13
116
1.12
0.09
1.2
1.2
mmol/l
11.4
11.5
—
6
33
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
42
441
0.95
0.09
1.2
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
61
0.82
0.08
1.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
63
0.79
0.08
2.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
146
1.10
0.08
1.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
64
1.09
0.08
1.4
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
35
332
1.06
0.08
1.6
1.6
—
—
—
0
0
(4268621)
17
156
1.09
0.08
2.8
2.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
133
0.90
0.07
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
133
0.90
0.07
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
133
0.90
0.07
1.3
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
81
0.86
0.07
4.1
4.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
80
0.87
0.07
1.4
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
9
86
1.05
0.07
1.0
1.2
u/l
164.3
358.0
—
9
77
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
86
1.05
0.07
1.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
88
1.02
0.07
1.0
1.3
nmol/l
138.1
140.3
—
9
88
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
132
0.91
0.06
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
132
0.91
0.06
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
132
0.91
0.06
1.3
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
15
138
1.09
0.06
1.3
1.9
e9/l
1.5
1.1
—
6
83
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
105
0.86
0.06
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
152
0.92
0.06
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
111
0.90
0.06
1.2
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
32
335
0.95
0.06
1.3
1.5
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
14
151
0.93
0.05
2.0
1.5
g/l
5.8
7.2
—
8
107
(3008037) Lactate [Moles/volume] in Venous blood
47
485
0.97
0.05
4.1
3.1
mmol/l
1.9
1.6
0.73
47
475
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
110
0.91
0.05
1.3
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
30
288
1.04
0.04
1.2
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
22
209
1.05
0.04
1.8
2.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
91
1.10
0.04
1.2
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
42
433
0.97
0.04
1.2
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
34
328
1.04
0.04
1.2
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
101
1.09
0.04
1.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
121
1.07
0.03
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
25
260
0.96
0.03
1.3
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
108
0.93
0.03
1.3
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
24
249
0.96
0.02
1.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
25
259
0.96
0.02
1.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
440
0.98
0.02
1.3
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
68
691
0.98
0.02
1.3
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
59
580
1.02
0.02
4.9
3.6
mmol/l
3.9
3.8
0.20
53
546
(1001926) Buprenorphine [Presence] in Urine by Screen method
20
208
0.96
0.02
1.3
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
22
212
1.04
0.02
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
26
268
0.97
0.02
1.4
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
103
1.07
0.02
1.3
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
23
223
1.03
0.01
1.1
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
25
257
0.97
0.01
2.1
2.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
263
1.03
0.01
1.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
26
266
0.98
0.00
1.4
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
26
266
0.98
0.00
1.4
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
105
1.05
0.00
1.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
265
1.02
0.00
1.3
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
15
151
0.99
0.00
1.9
1.5
g/l
3.3
2.9
—
9
107
(3024139) IgG subclass 3 [Mass/volume] in Serum
15
151
0.99
0.00
2.0
1.5
g/l
0.4
0.4
—
9
108
(3022806) Fractional oxyhemoglobin in Capillary blood
25
249
1.00
0.00
1.7
1.9
%
88.8
89.4
0.19
25
244
(3027944) Amphetamines [Presence] in Urine
26
259
1.00
0.00
1.4
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
26
259
1.00
0.00
1.0
1.1
iu/ml
400.4
104.8
—
5
53
(3005988) Vibrio sp identified in Specimen by Organism specific culture
26
261
1.00
0.00
1.3
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
27
269
1.00
0.00
1.4
2.3
mg/l
18.5
27.3
—
8
71
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
104
0.96
0.00
2.1
2.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
126
1.03
0.00
1.4
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
18
176
1.02
0.00
1.3
1.4
nmol/l
0.4
0.3
—
8
129
(4034850)
62
616
1.01
0.00
8.5
9.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
18
182
0.99
0.00
2.8
3.2
%
61.3
55.2
—
9
116
(3033705) Calcium.ionized [Moles/volume] in Venous blood
28
282
0.99
0.00
3.4
2.4
—
—
—
0
0
(3020891) Body temperature
76
758
1.00
0.00
5.1
4.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
267
1.01
0.00
1.3
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
313
0.99
0.00
1.3
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
12
117
1.03
0.00
3.0
3.0
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
11
107
1.03
0.00
1.4
1.8
%
11.3
12.1
—
6
39
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
14
143
0.98
0.00
1.9
1.7
mg/l
5.2
4.1
0.32
14
137
(3016018) Differential panel - Cerebral spinal fluid
18
177
1.02
0.00
1.2
1.4
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
65
0.92
0.00
1.7
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
2.6
—
0
9
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
4.8
—
22.9
—
0
9
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
8
0.00
0.00
0.0
5.3
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
355.4
—
0
5
(3013166) Neutrophils/100 leukocytes in Synovial fluid
6
62
0.97
0.00
1.0
1.4
%
89.0
57.1
—
6
53
(21494434) Karyotype in Bone marrow
16
160
1.00
0.00
1.0
1.2
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
208.4
—
0
6
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
51
0.98
0.00
1.8
1.5
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
15.1
—
0
6
(3047189) Immunofixation for 24 hour Urine
8
87
0.92
0.00
1.5
1.5
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
75
0.93
0.00
1.1
1.1
—
14.6
—
0
9
(3048879) Bone marrow aspiration report
5
51
0.98
0.00
1.2
1.6
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4027681)
8
85
0.94
0.00
1.4
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
2.0
—
0
5
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_THYTOXGOITMULT and mortality.

Females

Parameter HR [95% CI] p-value
E4_THYTOXGOITMULT 1.258 [1.14, 1.39] < 0.001
Birth year 0.995 [0.99, 1.0] 0.248

During the follow-up period (1.1.1998 — 31.12.2019), 1886 out of 8353 females with E4_THYTOXGOITMULT died.

Males

Parameter HR [95% CI] p-value
E4_THYTOXGOITMULT 1.226 [1.04, 1.45] 0.016
Birth year 0.988 [0.98, 1.0] 0.014

During the follow-up period (1.1.1998 — 31.12.2019), 410 out of 1483 males with E4_THYTOXGOITMULT died.

Mortality risk

Mortality risk for people of age

years, who have E4_THYTOXGOITMULT.

N-year risk Females Males
1 0.142% 0.251%
5 0.77% 1.437%
10 1.909% 3.544%
15 3.56% 6.687%
20 6.338% 11.5%

Relationships between endpoints

↥

Index endpoint: E4_THYTOXGOITMULT – Thyrotoxicosis with toxic multinodular goitre

GWS hits: 22

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data